Näytetään tulokset 1 - 10 / 9513
tulosta / sivu
Mitä julkaisutietoja palvelu sisältää?
Julkaisun nimi
Tekijät
Julkaisukanava
Vuosi

Adverse Events During Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer

Vertaisarvioitu
Avoin saatavuus
DOI
10.3233/BLC-190246
Salminen Antti P, Montoya Perez Ileana, Klén Riku, Ettala Otto O, Syvänen Kari T, Elo Laura L, Bostr...
bladder cancer2019

Benefit of adjuvant chemotherapy and pelvic lymph node dissection in pT3 and node positive bladder cancer patients treated with radical cystectomy

Vertaisarvioitu
Boström PJ; Mirtti T; Rhijn B van; Fleshner NE; Finelli A; Laato M; Jewett MA; Moore MJ; Sridhar S; ...
Bladder Cancer2016

Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy.

Vertaisarvioitu
DOI
10.3233/BLC-150032
Boström PJ, Mirtti T, van Rhijn B, Fleshner NE, Finelli A, Laato M, Jewett MA, Moore MJ, Sridhar S, ...
Bladder Cancer2016

Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy

Vertaisarvioitu
DOI
10.3233/BLC-150033
Boström PJ, Thoms J, Sykes J, Ahmed O, Evans A, van Rhijn BW, Mirtti T, Stakhovskyi O, Laato M, Marg...
bladder cancer2016

Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical Cystectomy

Vertaisarvioitu
Avoin saatavuus
DOI
10.3233/BLC-230086
van Gennep, Erik J.; Claps, Francesco; Boström, Peter J.; Shariat, Shahrokh F.; Neuzillet, Yann; Zlo...
Bladder cancer2024

A Systematic Review of Outcome Reporting, Definition and Measurement Heterogeneity in Non-Muscle Invasive Bladder Cancer Effectiveness Trials of Adjuvant, Prophylactic Treatment after Transurethral Resection

Vertaisarvioitu
DOI
10.3233/BLC-201510
Veskimae, Erik;Veskimae, Erik;Subbarayan, Selvarani;Campi, Riccardo;Campi, Riccardo;Carron, Domitill...
Bladder cancer2021

Nationwide analysis of survival after radical cystectomy for bladder cancer in Finland

Vertaisarvioitu
DOI
10.1080/0284186X.2023.2228446
Nikulainen, Ilkka; Salminen, Antti P.; Seikkula, Heikki; Högerman, Mikael; Perez, Ileana Montoya; Ko...
Acta oncologica2023

Genomic Subtyping in Bladder Cancer

Vertaisarvioitu
DOI
10.1007/s11934-020-0960-y
Jalanko, Tuomas; de Jong, Joep J.; Gibb, Ewan A.; Seiler, Roland; Black, Peter C.
Current urology reports2020

Pioglitazone and bladder cancer risk : a multipopulation pooled, cumulative exposure analysis

Vertaisarvioitu
DOI
10.1007/s00125-014-3456-9
Levin, Daniel; Buchan, Iain E; Bowker, Samantha L; Minhas-Sandhu, Jasjeet K; Zafari, Zafar; Marra, C...
Diabetologia2015

Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer

Vertaisarvioitu
Avoin saatavuus
DOI
10.1186/s13059-023-03026-4
Wong, Kim; Abascal, Federico; Ludwig, Latasha; Aupperle-Lellbach, Heike; Grassinger, Julia; Wright, ...
Genome biology2023

Adverse Events During Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer

Vertaisarvioitu
Avoin saatavuus
DOI
10.3233/BLC-190246
2019

Benefit of adjuvant chemotherapy and pelvic lymph node dissection in pT3 and node positive bladder cancer patients treated with radical cystectomy

Vertaisarvioitu
2016

Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy.

Vertaisarvioitu
DOI
10.3233/BLC-150032
2016

Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy

Vertaisarvioitu
DOI
10.3233/BLC-150033
2016

Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical Cystectomy

Vertaisarvioitu
Avoin saatavuus
DOI
10.3233/BLC-230086
2024

A Systematic Review of Outcome Reporting, Definition and Measurement Heterogeneity in Non-Muscle Invasive Bladder Cancer Effectiveness Trials of Adjuvant, Prophylactic Treatment after Transurethral Resection

Vertaisarvioitu
DOI
10.3233/BLC-201510
2021

Nationwide analysis of survival after radical cystectomy for bladder cancer in Finland

Vertaisarvioitu
DOI
10.1080/0284186X.2023.2228446
2023

Genomic Subtyping in Bladder Cancer

Vertaisarvioitu
DOI
10.1007/s11934-020-0960-y
2020

Pioglitazone and bladder cancer risk : a multipopulation pooled, cumulative exposure analysis

Vertaisarvioitu
DOI
10.1007/s00125-014-3456-9
2015

Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer

Vertaisarvioitu
Avoin saatavuus
DOI
10.1186/s13059-023-03026-4
2023